Health Condition 1: D332- Benign neoplasm of brain, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. All patients who have given consent for the study 2.Patients posted for elective intracranial tumor surgeries 3. ASA Grade 1 & 2 4.Age 18-60 years
Exclusion criteria
Exclusion criteria: 1. Known history of allergies to Propofol, Dexmedetomidine 2. Baseline Heart rate 3. Known cases of heart block 4. Known cases of Coronary Artery Disease 5. Known case of Diabetes mellitus type 2, hypertension, pregnancy 6. Previous craniotomy incision 7. Emergency Operations 8. ASA Grade 3 and 4 9. Patients on steroids, psychoactive medications, alpha 2 agonists or antagonists, beta blockers 10. Patients with any known endocrine disorders 11. Patients with hepatic impairment 12. Difficult intubation or repeated attempts of intubation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| compare the effects of propofol infusion and dexmedetomidine infusion on blood glucose levelsTimepoint: baseline (pre operative) 0 min (just before pin insertion) 20 min after pin insertion 40 min after pin insertion | — |
Secondary
| Measure | Time frame |
|---|---|
| The hemodynamic response after propofol infusion and dexmedetomidine infusionTimepoint: Baseline (pre operative) 0 min (just before pin insertion) 1 in after pin insertion 3 min after pin insertion 5 min after pin insertion | — |
Countries
India
Contacts
Institute Of Medical Sciences And SUM Hospital